The neuropsychological profile of symptomatic AIDS and ADC patients in the pre-HAART era: A meta-analysis

Journal of the International Neuropsychological Society

Volumn 12, Issue 3, 2006, Pages 368-382

  Cysique, Lucette A J ^a,d   Maruff, Paul ^b   Brew, Bruce J ^c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b LA TROBE UNIVERSITY   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AIDS dementia complex; Cognition; HIV AIDS; Meta analysis; Neuropsychological functioning; Neuropsychology

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; ATTENTION DISTURBANCE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; DISEASE SEVERITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEMORY DISORDER; MENTAL PERFORMANCE; MENTAL TASK; META ANALYSIS; MOTOR COORDINATION; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VERBAL MEMORY;

EID: 33745652676     PISSN: 13556177     EISSN: 14697661     Source Type: Journal    
DOI: 10.1017/S1355617706060401     Document Type: Article

References (74)

1. Andersen, R. (1976). Verbal and visuo-spatial memory. Scandinavian Journal of Psychology, 17, 198-204.
2. Andrewes, D., Bullen, J.G., Tomlinson, L., Elwes, R.D.C., & Reynolds, E.H. (1986). A comparative study of the effects of phenytoin and carbamezapine in new referrals with epilepsy. Epilepsia, 27, 128-134.
3. Ayers, M., Abrams, D., Newell, T., & Frieddrich, F. (1987). Performance of individuals with AIDS on the Luria-Nebraska neuropsychological battery. The International Journal of Clinical Neuropsychology, 9, 101-104.
4. Baldeweg, T., Catalan, J., Lovett, E., Gruzelier, J., Riccio, M., & Hawkins, D. (1995). Long-term zidovudine reduces neurocognitive deficits in HIV-1 infection. AIDS, 9, 589-596.
5. Basso, M.R. & Bornstein, R.A. (2000). Effects if immunosuppression and disease severity upon neuropsychological function in HIV infection. Journal of Clinical and Experimental Neuropsychology, 22, 104-114.
6. Becker, J.T. & Salthouse, T.A. (1999). Neuropsychological test performance in the Acquired Immunodeficiency Syndrome independent effects of diagnostic group on functioning. Journal of the International Neuropsychological Society, 5, 41-47.
7. Bornstein, R.A., Nasarallah, H.A., Para, M.F., Whitacre, C.C., Rosenberger, P., & Fass, R.J. (1993). Neuropsychological performance in symptomatic and asymptomatic HIV-infection. AIDS, 7, 519-524.
8. Brew, B.J. (2004). Evidence for a change in AIDS Dementia Complex in the era of Highly Active Antiretroviral Therapy and the possibility of new forms of AIDS Dementia Complex. AIDS, 18(Suppl. 1), S75-S78.
9. Brouwers, P, Hendricks, M., Lietzau, J.A., Pluda, J.M., Mitsuya, H., Broder, S., & Yarchoan, R. (1997). Effect of combination therapy with zidovudine and didanosine on neuropsychological functioning in patients with symptomatic HIV disease: A comparison of simultaneous and alternating regimens. AIDS, 11, 59-66.
10. Brouwers, P., Mohr, E., Hildebrand, K., Hendricks, M., Claus, J.J., Baron, I.S., Young, M., & Pierce, P. (1996). A novel approach to the determination and characterization of HIV dementia. Canadian Journal of Neurological Sciences, 23, 104-109.
11. CDC. (1987). Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR, 36(Suppl. 1), 1-15.
12. CDC. (1993). Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992, 41, No. RR-17.
13. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). New York: Academic Press.
14. Collie, A. & Maruff, P. (2000). The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment. Neurosciences and Biobehavioral Review, 24, 365-374.
15. Cummings, J.L. (1993). Fronto-subcortical circuits and human behavior. Archives of Neurology, 50, 873-880.
16. Cysique, L., Maruff, P., & Brew, B. (2004a). Prevalence and pattern of neuropsychological impairment in HIV/AIDS-infection across pre and post-highly active antiretroviral therapy eras: A combined study of 2 cohorts. Journal of Neurovirology, 10, 350-357.
17. Cysique, L., Maruff, P., & Brew, B. (2004b). Antiretroviral therapy in HIV infection: Are neurologically active drugs important? Archives of Neurology, 61, 1699-1704.
18. Cysique, L.A., Maruff, P., Darby, D., & Brew, B.J. (2006). The assessment of cognitive function in advanced HIV-1 infection and Aids Dementia Complex using a new computerized cognitive test battery. Archives of Clinical Neuropsychology, 21, 185-194.
19. Dubois, B. & Pillon, B. (1997). Cognitive deficits in Parkinson's disease. Journal of Neurology, 244, 2-8.
20. Dunbar, N.J. (1996). A model of neuropsychological impairment in AIDS dementia complex (Vol. 57 (1-B)): US: Univ Microfilms International.
21. Ellis, R.J., Hsia, K., Spector, S.A., Nelson, J.A., Heaton, R.K., Wallace, M.R., Abramson, I., Atkinson, J.H., Grant, I., & McCutchan, J.A. (1997). Cerebrospinal fluid Human immunodeficiency Virus type-1 RNA levels are elevated in neurocognitively impaired individuals with Acquired Immunodeficiency Syndrome. Annals of Neurology, 42, 679-688.
22. Gibbs, A., Andrewes, D., Szmukler, G., Mulhall, B., & Bowden, S. (1990). Early HIV-related neuropsychological impairment: Relationship to stage of viral infection. Journal of Clinical and Experimental Neuropsychology, 12, 766-780.
23. Grant, I., Atkinson, H.J., Hesselink, J.R., Kennedy, C.J., Richman, D.D., Spector, S.A., & McCutchan, J.A. (1987). Evidence for early central nervous system involvement in the Acquired Immunodeficiency Syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychological testing and magnetic resonance imaging. Annals of Internal Medicine, 107, 828-836.
24. Grassi, M.P., Perin, C., Clerici, F., Zocchetti, C., Cargnel, A., & Mangoni, A. (1993). Neuropsychological performances in HIV-1 infected drug abusers. Acta Neurologica Scandinavica, 88, 119-122.
25. Harrison, M.J., Newman, S.P., Hall-Craggs, M.A., Fowler, C.J., Miller, R., Kendall, B.E., Paley, M., Wilkinson, I., Sweeney, B., Lunn, S., Carter, S., & Williams, I. (1998). Evidence of CNS impairment in HIV infection: Clinical, neuropsychological, EEG, and MRI/MRS study. Journal of Neurology Neurosurgery and Psychiatry, 65, 301-307.
26. Heaton, R., Grant, I., Butters, N., White, D.A., Kirson, D., Atkinson, H.J., McCutchan, J.A., Taylor, M., Kelly, M.D., Ellis, R.J., Wolfson, T., Velin, R.A., Marcotte, T.D., Hesselink, J.R., Jernigan, T.L., Chandler, J., Wallace, M., Abramason, I., & the HNRC Group (1995). The HNRC 500-neuropsychology of HIV infection at different disease stages. Journal of the International Neuropsychological Society, 1, 231-251.
27. Hedges, L. (1994). Statistical considerations. In H. Cooper & L. Hedges (Eds.), The handbook of research synthesis, (pp. 29-38). New York: Russell Sage Foundation.
28. Hedges, L. & Olkin, I. (1985). Statistical methods for meta-analysis. Orlando, FL: Academic Press.
29. Hinkin, C., Cummings, J., Van Gorp, W., Satz, P., Mitrushina, M., & Freeman, D. (1990). Frontal/subcortical features of normal aging: An empirical analysis. Canadian Journal on Aging, 9, 104-119.
30. Howell, D. (2002). Statistical Methods for Psychology (5th ed.). Pacific Grove, CA: Thomson Learning.
31. Janssen, R., Comblath, D., Hopkins, J., Epstein, L.G., Foa, R.P., McArthur, J.C., & Price, W. (1991). Nomenclature and research case definitions for neurologic manifestations immunodeficiency virus type-1 (HIV-1): Reports of a working group of the American Academy of Neurology AIDS task force. Neurology, 41, 778-785.
32. Jansen, R., Saykin, A., Canon, L., Campbell, J., Pinsky, P., Hessol, N., O'Malley, P., Lifson, A., Doll, L., Rutherford, G., & Kaplan, J. (1989). Neurological and neuropsychological manifestations of HIV-1 infection: Association with AIDS-Related Complex but not asymptomatic HIV-1 infection. Annals of Neurology, 26, 592-600.
33. Joffe, R., Rubinow, D., Squillace, K., Lane, C., Duncan, C., & Fauci, A. (1986). Neuropsychiatric aspects of AIDS. Psychopharmacology Bulletin, 22, 684-688.
34. Josiassen, R., Curry, L., & Mancall, E. (1983). Development of neuropsychological deficits in Huntington's disease. Archives of Neurology, 40, 791-796.
35. Krikorian, R. & Wrobel, A.J. (1991). Cognitive impairment in HIV-infection. AIDS, 5, 1501-1507.
36. Lezak, M., Howieson, D., Loring, D., Hannay, J., & Fischer, J. (2004). Neuropsychological assessment (4th ed.). Oxford: Oxford University Press.
37. Lipsey, M. & Wilson, D. (2001). Practical Meta-analysis. London: Sage Publications.
38. Lunn, S., Skydsbjerg, M., Schulsinger, H., Parnas, J., Pedersen, J., & Mathiesen, L. (1991). A preliminary report on the neuropsychological sequelae of human immunodeficiency virus. Archives of General Psychiatry, 48, 139-142.
39. Mack, J. (1982). Short and long-term memory function in patients with unilateral hemispheric lesions. Paper presented at the International Neuropsychological Society North American Conference, Pittsburgh.
40. Martin, A., Heyes, M.P., Salazar, A.M., Kampen, D.L., Williams, J., Law, W.A., Coats, M.E., & Markey, S.P. (1992). Progressive slowing of reaction time and increasing cerebrospinal fluid concentration of quinolinic acid in HIV-1 affected individuals. Journal of Neuropsychiatry and Clinical Neurosciences, 4, 270-279.
41. Maruff, P., Currie, J., Malone, V., McArthur-Jackson, C., Mulhall, B., & Benson, E. (1994). Neuropsychological characterization of the AIDS Dementia Complex and rationalization of a test battery. Archives of Neurology, 51, 689-695.
42. Maruff, P., Malone, V., McAthur-Jackson, C., Mulhall, B., Benson, E., & Currie, J. (1995). Abnormalities of visual spatial attention in HIV infection and the HIV-associated dementia complex. The Journal of Neuropsychiatry and Clinical Neurosciences, 7, 325-333.
43. McArthur, J.C., Haughey, N., Gartner, S., Conant, K., Pardo, C.A., Nath, A., & Sacktor, N. (2003). Human Immunodeficiency Virus-associated dementia: An evolving disease. Journal of Neurovirology, 9, 205-221.
44. McCaffrey, R., Cousins, J., Westervelt, H., Martynowicz, M., Remick, S., Szebenyi, S., Wagle, W.A., Bottomley, P.A., Hardy, C.J., & Haase, R.F. (1995). Practice effects with the NIMH-AIDS abbreviated neuropsychological battery. Archives of Clinical Neuropsychology, 10, 241-250.
45. Navia, B.A., Cho, E.S., Petito, C.K., & Price, R.W. (1986). The aids dementia complex: II neuropathology. Annals of Neurology, 19, 525-535.
46. Newman, S.P., Lunn, S., & Harrison, M.J. (1995). Do asymptomatic HIV-seropositive individuals show cognitive deficit? AIDS, 9, 1211-1220.
47. Oldfield, R.C. & Wingfield, A. (1965). Response latencies in naming objects. Quarterly Journal of Experimental Psychology, 17, 273-281.
48. Peavy, G., Jacobs, D., Salmon, D., Butters, N., Delis, D., Taylor, M., Massman, P., Stout, J., Heindel, W., Kirson, D., Atkinson, J., Chandler, J., & Grant, I. (1994). Verbal memory performance of patients with Human Immunodeficiency Virus infection: Evidence of subcortical dysfunction. Journal of Clinical and Experimental Neuropsychology, 16, 508-523.
49. Perdices, M. & Cooper, D.A. (1989). Simple and choice reaction time in patients with Human Immunodeficiency Virus infection. Annals of Neurology, 25, 460-467.
50. Perdices, M. & Cooper, D.A. (1990). Neuropsychological investigation of patients with AIDS and ARC. Journal of Acquired Immune Deficiency Syndrome, 3, 555-564.
51. Petito, C., Roberts, B., Cantando, J., Rabinstein, A., & Duncan, R. (2001). Hippocampal injury and alterations in neuronal chemokine co-receptor expression in patients with AIDS. Journal of Neuropathology and Experimental Neurology, 60, 377-385.
52. Power, C., Selnes, O., Grim, J., & McArthur, J (1995). HIV dementia scale: A rapid screening test. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 8, 273-278.
53. Price, R.W. & Brew, B.J. (1988). The Aids Dementia Complex. Journal of Infectious Disease, 158, 1079-1083.
54. Reger, M., Wesh, R., Razani, J., Martin, D.J., & Boone, K.B. (2002). A meta-analysis of the neuropsychological sequelae of HIV-infection. Journal of the International Neuropsychological Society, 8, 410-424.
55. Rennick, P.M. (1979). Color-naming and visual search tests for repeatable cognitive-perceptual motor battery. Grosse Point Park, MI: Axon Publishing Company.
56. Rubinow, D., Berrettini, C., Brouwers, P., & Lane, H. (1988). Neuropsychiatric consequences of AIDS. Annals of Neurology, 23(suppl.), S24-S26.
57. Sacktor, N.C., Bacellar, H., Hoover, D.R., Nance-Sproson, T.E., Selnes, O.A., Miller, E.N., Dal Pan, G.J, Kleeberger, C., Brown, A., Saah, A., & McArthur, J.C. (1996). Psychomotor slowing in HIV infection: A predictor of dementia, AIDS and death. Journal of Neurovirology, 2, 404-410.
58. Saykin, A., Jansen, R., Sprehn, G., Kaplan, J., Spira, T., & O'Connor, B. (1991). Longitudinal evaluation of neuropsychological function in homosexual men with HIV-infection: 18-month follow-up. The Journal of Neuropsychiatry and Clinical Neurosciences, 3, 286-298.
59. Selnes, O.A., Galai, N., Bacellar, M.A., Miller, E.N., Becker, J.T., Wesch, J., Van Gorp, W., & McArthur, J.C. (1995). Cognitive performance after progression to AIDS: A longitudinal study from the Multicenter AIDS cohort study. Neurology, 45, 267-275.
60. Seltzer, R. & Mack, J. (1981). Visual design copying in patients with unilateral cerebral lesions. Paper presented at the International Neuropsychological Society European Conference, Bergen.
61. Sevigny, J.J., Albert, S.M., McDermott, M.P., McArthur, J.C., Sacktor, N., Conant, K., Schifitto, G., Selnes, O.A., Stern, Y., McClernon, D.R., Palumbo, D., Kieburtz, K., Riggs, G., Cohen, B., Epstein, L.G., & Marder, K. (2004). Evaluation of HIV RNA and markers of immune activation as predictors of HIV-Associated Dementia. Neurology, 63, 2084-2090.
62. Sidtis, J.J., Gatsonis, C., Price, R.W., Singer, E.J., Collier, A.C., Richman, D.D., Hirsch, M.S., Schaerf, F.W., Fischl, M.A., Kieburtz, K., Simpson, D., Koch, M.A., Feinberg, J., Dafni, U., & the AIDS Trials Group. (1993). Zidovudine treatment of the aids dementia complex: Results of a placebo-controlled trial. Annals of Neurology, 33, 343-349.
63. Skoraszewski, M., Ball, J., & Mikulka, P. (1991). Neuropsychological functioning of HIV-infected males. Journal of Clinical and Experimental Neuropsychology, 13, 278-290.
64. Spreen, O. & Strauss, E. (1998). A compendium of neuropsychological tests (2nd ed.). New York: Oxford University Press.
65. Stelmach, G., Phillips, J., & Chau, A. (1989). Visuo-spatial processing in parkinsonians. Neuropsychologia, 27, 485-493.
66. Tozzi, V., Balestra, P., Galgani, S., Narciso, P., Ferri, F., Sebastiani, G., D'Amato, C., Affricano, C., Pigorini, F., Pau, M.F., De Felici, A., & Benedetto, A. (1999). Positive and sustained effects of Highly Active Antiretroviral Therapy on HIV-1 associated neurocognitive impairment. AIDS, 13, 1889-1897.
67. Tross, S., Price, R.W., Navia, B., Thaler, H.T., Gold, J., Hirsch, D.A., & Sidtis, J.J. (1988). Neuropsychological characterization of the AIDS Dementia Complex: A preliminary report. AIDS, 2, 81-88.
68. Van Gorp, W., Mandelkern, M., Gee, M., Hinkin, C., Stern, C., Paz, D., Dixon, W., Evans, G., Flynn, F., & Frederick, C.J. (1992). Cerebral metabolic dysfunction in AIDS: Findings in a sample with and without dementia. Journal of Neuropsychiatry and Clinical Neurosciences, 4, 280-287.
69. Van Gorp, W.G., Miller, E.N., Satz, P., & Visscher, B. (1989). Neuropsychological performance in HIV-1-immunocompromised patients: A preliminary report. Journal of Clinical and Experimental Neuropsychology, 11, 763-773.
70. White, D.A., Heaton, R., & Monsch, A.U. (1995). Neuropsychological studies of asymptomatic Human Immunodeficiency Virus-type 1 infected individuals. Journal of the International Neuropsychological Society, 1, 304-315.
71. White, D.A., Taylor, M.J, Butters, N., Mack, C., Salmon, D.P., Peavy, G., Ryan, L., Heaton, R.K., Atkinson, H.J., Chandler, J., Grant, I., & the HNRC Group. (1997). Memory for verbal information in individuals with HIV Associated Dementia Complex. Journal of Clinical and Experimental Neuropsychology, 19, 357-366.
72. Wilson, D. (2001). Effect size determination program. Retrieved December 2004, from http://mason.Gmu.Edu/~dwilsonb/ma.Html.
73. Worth, J., Savage, C.R., Baer, L., Esty, E.K., & Navia, B.A. (1993). Computer-based neuropsychological screening for AIDS Dementia Complex. AIDS, 7, 677-681.
74. Zakzanis, K.K. (2001). Statistics to tell the truth, the whole truth, and nothing but the truth: Formulae, illustrative numerical examples, and heuristic interpretation of effect sizes analyses for neuropsychological researchers. Archives of Clinical Neuropsychology, 16, 653-667.